Interferon α/β-mediated inhibition and promotion of interferon γ: STAT1 resolves a paradox
- 1 July 2000
- journal article
- research article
- Published by Springer Nature in Nature Immunology
- Vol. 1 (1) , 70-76
- https://doi.org/10.1038/76940
Abstract
Induction of high systemic levels of type 1 interferons (IFNs) IFN-α and IFN-β is a hallmark of many viral infections. In addition to their potent antiviral effects, these cytokines mediate a number of immunoregulatory functions and can promote IFN-γ expression in T cells. However, during viral infections of mice IFN-γ production is not always observed at the same time as systemic IFN-α/β production and when, elicited at these times, is IFN-α/β–independent. We demonstrate that type 1 interferons not only fail to induce, but also act to inhibit, IFN-γ expression by both NK and T cells. The mechanism of inhibition is dependent upon the IFN-α/β receptor and the signal transducer and activator of transcription 1 (STAT1). In the absence of STAT1, not only are the IFN-α/β–mediated inhibitory effects completely abrogated, but the cytokines themselves can induce IFN-γ expression. These results indicate that endogenous biochemical pathways are in place to negatively regulate NK and T cell IFN-γ expression elicited by IFN-α/β or other stimuli, at times of innate responses to viral infections. They also show that type 1 interferon signaling can occur through STAT1-dependent and independent mechanisms and suggest that efficient induction of IFN-γ expression by IFN-α/β requires STAT1 regulation. Such immunoregulatory pathways may be critical for shaping the endogenous innate and virus-specific adaptive immune responses to viral infections.Keywords
This publication has 38 references indexed in Scilit:
- Stat1 as a Component of Tumor Necrosis Factor Alpha Receptor 1-TRADD Signaling Complex To Inhibit NF-κB ActivationMolecular and Cellular Biology, 2000
- Two Roads Diverged: Interferon α/β– and Interleukin 12–mediated Pathways in Promoting T Cell Interferon γ Responses during Viral InfectionThe Journal of Experimental Medicine, 1999
- NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate CytokinesAnnual Review of Immunology, 1999
- Selective Expression of an Interleukin-12 Receptor Component by Human T Helper 1 CellsThe Journal of Experimental Medicine, 1997
- Induction of Bystander T Cell Proliferation by Viruses and Type I Interferon in VivoScience, 1996
- Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral DiseaseCell, 1996
- Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK–STAT Signaling PathwayCell, 1996
- Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration.The Journal of Experimental Medicine, 1995
- Roles of Protein-tyrosine Phosphatases in Stat1α-mediated Cell SignalingPublished by Elsevier ,1995
- Functional Role of Type I and Type II Interferons in Antiviral DefenseScience, 1994